Oscar Health Inc. (OSCR) Tops Q3 EPS by 20c

Oscar Health Inc. (NYSE: OSCR) reported Q3 EPS of ($0.29), $0.20 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.41 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Target raises full-year sales forecast amid ongoing turnaround drive
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance